Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Clasificación en acciones #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Precio por acción
$0.00023723
Última sincronización: 2024-08-26
Capitalización bursátil
$1.41K
Cambio (1 día)
111.67%
Cambio (1 año)
0.00%
País
FR
Comercio Pharnext S.A. (ALPHA)

Categoría

EPS de Pharnext S.A. (ALPHA)
EPS a fecha de December 2023 TTM: $-77.35M
Según los últimos informes financieros y el precio de las acciones de Pharnext S.A., el EPS actual de la empresa (TTM) es $-77.35M. Al final del año 2022, la empresa tenía un EPS de $-11.16K una disminución en comparación con al EPS de 2021, que fue de $-11.45K.
Historial de EPS de Pharnext S.A. desde 2013 hasta 2026
EPS al final de cada año
Año EPS Cambiar
2026 (TTM) $-77.35M 35,598,509.46%
2023 $-217.28 -98.05%
2022 $-11.16K -2.49%
2021 $-11.45K 69.15%
2020 $-6.77K -21.06%
2019 $-8.57K -15.43%
2018 $-10.14K -100.00%
2017 $-6.00Qa 14.04%
2016 $-5.26Qa 44,068,612,420.18%
2015 $-11.94M -8.06%
2014 $-12.98M 1.29%
2013 $-12.82M 0.00%
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
$17.32 -100.00%
US
$27.74 -100.00%
NL
- -
CH
$13.70 -100.00%
BE
- -
KR